- £371.80m
- £332.55m
- £159.13m
- 82
- 22
- 38
- 42
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 61.8 | 83 | 90.5 | 137 | 159 |
Cost of Revenue | |||||
Gross Profit | 29.5 | 39.1 | 45.5 | 69.6 | 69.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 42.8 | 56.8 | 61.3 | 105 | 159 |
Operating Profit | 19 | 26.2 | 29.2 | 32.3 | 0.042 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 19.2 | 26.2 | 29.1 | 28.7 | -1.08 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16.6 | 21.9 | 23.7 | 23.5 | -3.75 |
Net Income Before Extraordinary Items | |||||
Net Income | 16.6 | 21.9 | 23.7 | 23.5 | -3.75 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 16.6 | 21.9 | 23.7 | 23.5 | -3.75 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.129 | 0.168 | 0.182 | 0.169 | 0.124 |